- Recommendation ID
- NG101/4
- Question
Neoadjuvant endocrine therapy in premenopausal women:- Is neoadjuvant endocrine therapy safe in premenopausal women with early breast cancer?
- Any explanatory notes
(if applicable) To find out why the committee made the research recommendation on neoadjuvant endocrine therapy in premenopausal women, see rationale and impact.
Source guidance details
- Comes from guidance
- Early and locally advanced breast cancer: diagnosis and management
- Number
- NG101
- Date issued
- July 2018
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/07/2018 |